{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:14:48Z","timestamp":1783509288375,"version":"3.55.0"},"reference-count":35,"publisher":"MDPI AG","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>All clinicians are ethically obliged to prescribe responsibly and cautiously to diminish the potential for opioid diversion and to help minimize the growth of the current opioid abuse epidemic. Podiatric physicians should establish procedures to better control and limit opioid prescription and develop analgesic regimens to treat pain. The main purpose and goal of this review is to present data congruent with clinical, medical, and legal reports for allowing an appreciation of the possibility of the risk assumed when ordering and prescribing opioids within the podiatric medical profession. First, the concept and process of risk management, illustrated using a root cause analysis approach, is introduced, and application of these principles specifically to opioid prescribing is presented. Then, several examples found in both the medical and legal literature documenting the reasons for opioid prescription risk are presented. Finally, mitigating strategies for safe opioid prescribing are offered so that mitigation of opioid harm can be possible and realized by the lower-extremity specialist. Risk management strategies and tools to mitigate opioid harm, lessen opioid adverse effects, and reduce opioid deaths are presented narratively and graphically.<\/jats:p>","DOI":"10.7547\/21-166","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T11:56:21Z","timestamp":1699358181000},"source":"Crossref","is-referenced-by-count":1,"title":["Risk Management and Mitigating Risk Opportunities for Opioid Prescribing"],"prefix":"10.3390","volume":"113","author":[{"given":"Robert G.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"B1","series-title":"J Clin Rev Case Rep","first-page":"423","article-title":"The opioid crisis viewed through the lens of a black and white camera","volume":"5","author":"Smith RG","year":"2020","unstructured":"Smith RG: The opioid crisis viewed through the lens of a black and white camera. J Clin Rev Case Rep 5: 423, 2020."},{"key":"B2","series-title":"Foot Ankle Q","first-page":"143","article-title":"Using clinical-based evidence as the sextant to prescribe and navigate through the opioid crisis: opioid crisis management","volume":"29","author":"Smith RG","year":"2018","unstructured":"Smith RG: Using clinical-based evidence as the sextant to prescribe and navigate through the opioid crisis: opioid crisis management. Foot Ankle Q 29: 143, 2018."},{"key":"B3","article-title":"Understanding the epidemic: drug overdose","year":"2021","unstructured":"CDC: Understanding the epidemic: drug overdose. Available at: https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html. Accessed July 3, 2021."},{"key":"B4","series-title":"Biosocieties","first-page":"217","article-title":"White opioids: pharmaceutical race and the war on drugs that wasn\u2019t","volume":"12","author":"Netherland J","year":"2017","unstructured":"Netherland J, Hansen H: White opioids: pharmaceutical race and the war on drugs that wasn\u2019t. Biosocieties 12: 217, 2017."},{"key":"B5","article-title":"Doctors and dentists still flooding U.S. with opioid prescriptions","author":"Mann B","year":"2020","unstructured":"Mann B: Doctors and dentists still flooding U.S. with opioid prescriptions. Available at: https:\/\/apple.news\/AQKZh9pNoTzKraATzyyBeQg. Published July 17, 2020. Accessed July 3, 2021."},{"key":"B6","series-title":"Cureus","first-page":"e3733","article-title":"Racial bias in the US opioid epidemic: a review of the history of systemic bias and implications for care","volume":"10","author":"Santoro TN","year":"2018","unstructured":"Santoro TN, Santoro JD: Racial bias in the US opioid epidemic: a review of the history of systemic bias and implications for care. Cureus 10: e3733, 2018."},{"key":"B7","series-title":"Pain Ther","first-page":"13","article-title":"A brief history of the opioid epidemic and strategies for pain medicine","volume":"7","author":"Jones MR","year":"2018","unstructured":"Jones MR, Viswanath O, Peck J: A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther 7: 13, 2018."},{"key":"B8","article-title":"Big pharma companies are the \u201cdrug kingpins\u201d of the opioid crisis","author":"Bachtell J","year":"2019","unstructured":"Bachtell J: Big pharma companies are the \u201cdrug kingpins\u201d of the opioid crisis. Available at: https:\/\/www.peoplesworld.org\/article\/big-pharma-companies-are-the-drug-kingpins-of-the-opioid-crisis\/. Published August 1, 2019. Accessed July 7, 2021."},{"key":"B9","series-title":"Am J Public Health","first-page":"22","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee A","year":"2009","unstructured":"Van Zee A: The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 99: 22, 2009."},{"key":"B10","series-title":"Pain Med","first-page":"76","article-title":"Differences in opioid prescribing among generalist physicians, nurse practitioners, and physician assistants","volume":"21","author":"Ellenbogen MI","year":"2020","unstructured":"Ellenbogen MI, Segal JB: Differences in opioid prescribing among generalist physicians, nurse practitioners, and physician assistants. Pain Med 21: 76, 2020."},{"key":"B11","article-title":"Purdue targeted nurse practitioners, PAs, but doctors had to sign off on all prescriptions","author":"Nelson KL","year":"2018","unstructured":"Nelson KL: Purdue targeted nurse practitioners, PAs, but doctors had to sign off on all prescriptions. Knoxnews.com. Available at: https:\/\/www.knoxnews.com\/story\/news\/health\/2018\/08\/19\/opioid-epidemic-lawsuit-purdue-pharma-oxycontin\/1016809002\/. Published August 19, 2018. Accessed July 7, 2021."},{"key":"B12","series-title":"JAPMA","first-page":"367","article-title":"A review of opioid analgesics frequently prescribed by podiatric physicians","volume":"96","author":"Smith RG","year":"2006","unstructured":"Smith RG: A review of opioid analgesics frequently prescribed by podiatric physicians. JAPMA 96: 367, 2006."},{"key":"B13","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"1","article-title":"CDC guideline for prescribing opioids for chronic pain","volume":"65","year":"2016","unstructured":"CDC guideline for prescribing opioids for chronic pain. MMWR Morb Mortal Wkly Rep 65: 1, 2016. Available at: https:\/\/www.cdc.gov\/mmwr\/volumes\/65\/rr\/pdfs\/rr6501e1.pdf. Accessed July 7, 2021."},{"key":"B14","series-title":"Jt Comm J Qual Patient Saf","first-page":"1","article-title":"The time for opioid stewardship is now","volume":"45","author":"Sandbrin F","year":"2019","unstructured":"Sandbrin F, Uppal R: The time for opioid stewardship is now. Jt Comm J Qual Patient Saf 45: 1, 2019."},{"key":"B15","series-title":"West J Emerg Med","first-page":"198","article-title":"Stewarding recovery from opioid crisis through health system initiatives","volume":"20","author":"Perrone J","year":"2019","unstructured":"Perrone J, Weiner SG, Nelson LS: Stewarding recovery from opioid crisis through health system initiatives. West J Emerg Med 20: 198, 2019."},{"key":"B16","series-title":"Jt Comm J Qual Patient Saf","first-page":"3","article-title":"A health system-wide initiative to decrease opioid-related morbidity and mortality","volume":"45","author":"Weiner SG","year":"2019","unstructured":"Weiner SG, Price CN, Atalay AJ: A health system-wide initiative to decrease opioid-related morbidity and mortality. Jt Comm J Qual Patient Saf 45: 3, 2019."},{"key":"B17","series-title":"J Bone Joint Surg Am","first-page":"180","article-title":"Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures","volume":"100","author":"Sabatino MJ","year":"2018","unstructured":"Sabatino MJ, Kunkel ST, Ramkumar DB: Excess opioid medication and variation in prescribing patterns following common orthopaedic procedures. J Bone Joint Surg Am 100: 180, 2018."},{"key":"B18","series-title":"J Am Acad Orthop Surg","first-page":"e166","article-title":"Opioid prescribing practices of orthopaedic surgeons: results of a national survey","volume":"27","author":"Raneses E","year":"2019","unstructured":"Raneses E, Secrist ES, Freedman KB: Opioid prescribing practices of orthopaedic surgeons: results of a national survey. J Am Acad Orthop Surg 27: e166, 2019."},{"key":"B19","series-title":"JAMA","first-page":"1672","article-title":"Prescription opioids, overdose deaths, and physician responsibility","volume":"300","author":"McLellan AT","year":"2008","unstructured":"McLellan AT, Turner B: Prescription opioids, overdose deaths, and physician responsibility. JAMA 300: 1672, 2008."},{"key":"B20","series-title":"Foot Ankle Int","first-page":"1257","article-title":"Prospective evaluation of utilization patterns and prescribing guidelines of opioid consumption following orthopedic foot and ankle surgery","volume":"39","author":"Saini S","year":"2018","unstructured":"Saini S, McDonald EL, Shakked R: Prospective evaluation of utilization patterns and prescribing guidelines of opioid consumption following orthopedic foot and ankle surgery. Foot Ankle Int 39: 1257, 2018."},{"key":"B21","series-title":"Foot Ankle Int","first-page":"149","article-title":"Pain management after outpatient foot and ankle surgery","volume":"39","author":"Gupta A","year":"2018","unstructured":"Gupta A, Roberts MM, Sanders EA: Pain management after outpatient foot and ankle surgery. Foot Ankle Int 39: 149, 2018."},{"key":"B22","series-title":"Foot Ankle Int","first-page":"649","article-title":"Opioid consumption following foot and ankle surgery","volume":"39","author":"Merrill HM","year":"2018","unstructured":"Merrill HM, Dean DM, Mottla JL: Opioid consumption following foot and ankle surgery. Foot Ankle Int 39: 649, 2018."},{"key":"B23","series-title":"Obstet Gynecol","first-page":"150","article-title":"Opioid knowledge and prescribing practices among obstetrician-gynecologists","volume":"131","author":"Madsen AM","year":"2018","unstructured":"Madsen AM, Stark LM, Has P: Opioid knowledge and prescribing practices among obstetrician-gynecologists. Obstet Gynecol 131: 150, 2018."},{"key":"B24","series-title":"JAPMA","doi-asserted-by":"publisher","DOI":"10.7547\/20-223","article-title":"Postoperative opioid prescribing practice in foot and ankle surgery","author":"Brooks BM","year":"2021","unstructured":"Brooks BM, Brooks BM, Brooks BM: Postoperative opioid prescribing practice in foot and ankle surgery. JAPMA [March 3, 2021; doi: 10.7547\/20-223]."},{"key":"B25","article-title":"Opioids top list of malpractice claims linked to medications. Medscape Web site","volume":"16","author":"Lowes R","year":"2017","unstructured":"Lowes R: Opioids top list of malpractice claims linked to medications. Medscape Web site. Available at: https:\/\/www.medscape.com\/viewarticle\/887127?form=fpf. Published October 16, 2017. Accessed July 7, 2021."},{"key":"B26","article-title":"Legally prescribed painkillers are very often a precursor to addiction, overdose, and drug abuse","author":"McLaughlin","year":"2021","unstructured":"McLaughlin & Lauricella PC: Legally prescribed painkillers are very often a precursor to addiction, overdose, and drug abuse. Available at: https:\/\/ml-law.net\/medical-errors-misdiagnosis-negligence\/opioid-malpractice-claims-lawsuits. Accessed July7, 2021."},{"key":"B27","article-title":"The risk of medical malpractice lawsuits for opioid-prescribing physician","author":"Hazi A","year":"2019","unstructured":"Hazi A: The risk of medical malpractice lawsuits for opioid-prescribing physician. Available at: https:\/\/burnswhite.com\/the-risk-of-medical-malpractice-lawsuits-for-opioid-prescribing-physicians\/. Published August 19, 2019. Accessed July 7, 2021."},{"key":"B28","series-title":"Inj Epidemiol","first-page":"50","article-title":"Characteristics of criminal cases against physicians charged with opioid-related offenses reported in the US news media, 1995-2019","volume":"7","author":"Berman JB","year":"2020","unstructured":"Berman JB, Li G: Characteristics of criminal cases against physicians charged with opioid-related offenses reported in the US news media, 1995-2019. Inj Epidemiol 7: 50, 2020."},{"key":"B29","series-title":"Pain Physician","first-page":"E297","article-title":"The current state of opioid prescribing and Drug Enforcement Agency (DEA) action against physicians: an analysis of DEA database 2004-2017","volume":"23","author":"Kim DD","year":"2020","unstructured":"Kim DD, Sibai N: The current state of opioid prescribing and Drug Enforcement Agency (DEA) action against physicians: an analysis of DEA database 2004-2017. Pain Physician 23: E297, 2020."},{"key":"B30","series-title":"Wounds","first-page":"146","article-title":"Mitigating opioid crisis opioid stewardship","volume":"32","author":"Smith RG","year":"2020","unstructured":"Smith RG: Mitigating opioid crisis opioid stewardship. Wounds 32: 146, 2020."},{"key":"B31","series-title":"Podiatry Management","first-page":"105","article-title":"Mitigating the opioid crisis for the podiatric physician: remember the \u201cMORPHINE\u201d acronym","volume":"39","author":"Smith RG","year":"2020","unstructured":"Smith RG: Mitigating the opioid crisis for the podiatric physician: remember the \u201cMORPHINE\u201d acronym. Podiatry Management 39: 105, 2020."},{"key":"B32","series-title":"Am Fam Physician","first-page":"231","article-title":"Dobbie AE: Appropriate prescribing of medications: an eight-step approach","volume":"75","author":"Pollock M","year":"2007","unstructured":"Pollock M, Bazaldua OV, Dobbie AE: Appropriate prescribing of medications: an eight-step approach. Am Fam Physician 75: 231, 2007."},{"key":"B33","year":"2021","unstructured":"Centers for Disease Control and Prevention: Assessing benefits and harms of opioid therapy. Available at: https:\/\/www.cdc.gov\/opioids\/providers\/prescribing\/pdf\/assesing-benefits-harms-of-opioid-therapy.pdf. Accessed July 7, 2021."},{"key":"B34","series-title":"Responsibility for Drug-Induce Injury: A Reference Book for Lawyers, the Health Professions and Manufacturers","author":"Dukes MN","year":"1988","unstructured":"Dukes MN, Swartz B; World Health Organization. Responsibility for Drug-Induce Injury: A Reference Book for Lawyers, the Health Professions and Manufacturers, Elsevier, Amsterdam, 1988."},{"key":"B35","series-title":"J Gen Intern Med","first-page":"633","article-title":"Prescription opioids, time to rethink how we assess risk","volume":"35","author":"Kay C","year":"2020","unstructured":"Kay C: Prescription opioids, time to rethink how we assess risk. J Gen Intern Med 35: 633, 2020."}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/113\/5\/21-166.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/113\/5\/21-166.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/113\/5\/21-166.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:19:23Z","timestamp":1783505963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/113\/5\/21166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.7547\/21-166","relation":{},"ISSN":["8750-7315"],"issn-type":[{"value":"8750-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}